STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer
Jiaqi Shi, Caiqi Liu, Shengnan Luo, Tingyu Cao, Binlin Lin, Meng Zhou, Xiao Zhang, Song Wang, Tongsen Zheng, Zheng‐Xiang Li
Topics & Concepts
StingAgonistBlockadeColorectal cancerCombination therapyImmunotherapyStimulator of interferon genesCancer researchCD8MedicinePharmacologyT cellCancer immunotherapyImmune systemCancerImmunologyInternal medicineReceptorInnate immune systemEngineeringAerospace engineeringinterferon and immune responsesImmune cells in cancerImmune Cell Function and Interaction